FDA Approves Sorilux for Adolescent Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
While clinical AI dominates industry headlines, the most immediate, low-risk opportunities for plastic surgeons lie in front-office automation. Weave CEO Brett White discusses how implementing AI in your administrative workflows can streamline patient inquiries, capture more consultations, and reduce staff burnout without losing the personal touch.